Citations

Showing 10 of 108104 citations.

Current approaches to management of newly diagnosed multiple myeloma
Goel, Utkarsh , Usmani, Saad Z. , Kumar, Shaji , Usmani, Saad

Mayo Clinic

American Journal of Hematology | March 2, 2022 | Volume: 97 | Issue: S1 | Pages: No page available

10.1002/ajh.26512 | PMID 35234302 Get It

AbstractMajor developments in the treatment of multiple myeloma (MM) over the past decade have led to a continued improvement in survival. Significant progress has been made with deeper and longer remissions seen with newer treatment approaches—both for induction as well as maintenance therapy. The treatment approach to MM is guided by several factors including patient age, frailty, comorbidities, eligibility for autologous stem cell transplantation (ASCT), and risk stratification into standard‐risk or high‐risk MM. High‐risk MM is defined by the presence of t(4;14), t(14;16), t(14;20), del (17p), TP53 mutation, or gain (1q). Transplant eligible patients should receive 4–6 cycles of induction followed by stem cell collection. Patients can then undergo ASCT, or continue induction therapy and shift to maintenance, delaying ASCT till first relapse. Transplant ineligible patients should receive induction therapy followed by maintenance. For induction therapy prior to ASCT, a proteasome inhibitor‐IMiD combination remains standard with monoclonal antibody‐based quadruplets preferred in high‐risk patients. Among transplant ineligible patients, those with standard‐risk MM should receive DRd continued until disease progression, while bortezomib containing regimens (VRd or VRd lite) can be considered for high‐risk patients. Finally, standard‐risk patients should receive lenalidomide maintenance after induction/ASCT, while proteasome inhibitor‐IMiD combinations should be used for high‐risk patients.
Primary Colonic Diffuse Large B-Cell Lymphoma in Bloom Syndrome
Benanzer, Tessa M., Kamboj, Amrit K. , Sweetser, Seth

Mayo Clinic

ACG Case Reports Journal | March 2, 2022 | Volume: 9 | Issue: 2 | Pages: e00686

10.14309/crj.0000000000000686 Get It

ABSTRACT Bloom syndrome is an inherited disorder involving a characteristic phenotype of short stature, photosensitive rash, immunodeficiency, and an early predisposition to various cancers, including lymphoma and colorectal neoplasms. We present a patient with Bloom syndrome found to have a colonic mass secondary to diffuse large B-cell lymphoma highlighting the importance of cancer screening and surveillance in these patients.
Leak closure following left atrial appendage exclusion procedures: A multicenter registry
Killu, Ammar M. , Adeola, Oluwaseun , Sugrue, Alan , Simard, Trevor , Friedman, Paul A. , Kawsara, Akram , Horton, Rodney , Natale, Andrea , Holmes, David R. , Sugrue, Alan M, Simard, Trevor , Kawsara, Akram , Holmes, David R , Natale, Andrea , Rocca, Domenico G. Della , Ellis, Christopher R. , Alkhouli, Mohamad

Mayo Clinic

Catheterization and Cardiovascular Interventions | March 2, 2022 | Volume: 99 | Issue: 6 | Pages: 1867-1876

10.1002/ccd.30139 | PMID 35233927 Get It

AbstractBackgroundThough infrequent, incomplete left atrial appendage closure (LAAC) may result from residual leaks. Percutaneous closure has been described though data is limited.MethodsWe compiled a registry from four centers of patients undergoing percutaneous closure of residual leaks following LAAC via surgical means or with the Watchman device. Leak severity was classified as none (no leak), mild (1–2 mm), moderate (3–4 mm), or severe (≥5 mm). Procedural and clinical success was defined as the elimination of leak or mild residual leak at the conclusion of the procedure or follow‐up, respectively.ResultsOf 72 (age 72.2 ± 9.2 years; 67% male) patients, 53 had undergone prior LAAC using the Watchman device and 19 patients surgical LAAC. Mean CHADS2‐VA2Sc score was 4.0 ± 1.8. The median leak size was 5 mm, range: 2–13). A total of 13 received Amplatzer Vascular Plug‐II, 18 received Amplatzer Duct Occluder‐II and 40 patients received coils. One underwent closure using a 21 mm‐Watchman. Procedural success was 94%. Zero surgical and nine Watchman patients (13%) had a residual leak at procedural‐end (five mild, three moderate, and one severe)—only one patient had no reduction in leak size. Overall leak size reduction was 94%. Two (3%) had intraoperative pericardial effusion. There were no device embolizations, device‐related thrombi, or procedural deaths. Clinical success was maintained at 94%. Two had cerebrovascular accidents—at 2 days (transient ischemic attack) and 10 months postprocedure. Two had major bleeding outside the 30‐day periprocedural window.ConclusionPercutaneous closure of residual leaks following left atrial appendage closure is feasible and associated with good outcomes. The procedural risk appears to be satisfactory.
Targeted Regional Optimization in Action: Dose-dependent End-organ Ischemic Injury with Partial Aortic Occlusion in the Setting of Ongoing Liver Hemorrhage
Ronaldi, Alley E., Lauria, Alexis L., Paterson, Jeanette E., Kersey, Alexander J., Leung, Lai Yee, Burmeister, David M., Baer, David G., White, Paul W., Rasmussen, Todd E., White, Joseph M., Ronaldi, Alley E., Lauria, Alexis L., Paterson, Jeanette E., Kersey, Alexander J., Leung, Lai Yee, Burmeister, David Mark , Baer, David G., White, Paul W., Rasmussen, Todd E., White, Joseph M.

Mayo Clinic

Shock | March 2, 2022 | Volume: 57 | Issue: 5 | Pages: 732-739

10.1097/shk.0000000000001922 | PMID 35234207 Get It

ABSTRACT Introduction: Targeted regional optimization (TRO) describes partial resuscitative endovascular balloon occlusion of the aorta strategy that allows for controlled distal perfusion to balance hemostasis and tissue perfusion. This study characterized hemodynamics at specific targeted distal flow rates in a swine model of uncontrolled hemorrhage to determine if precise TRO by volume was possible. Methods: Anesthetized swine were subjected to liver laceration and randomized into TRO at distal flows of 300 mL/min (n = 8), 500 mL/min (n = 8), or 700 mL/min (n = 8). After 90 min, the animals received damage control packing and were monitored for 6 h. Hemodynamic parameters were measured continuously, and hematology and serologic labs obtained at predetermined intervals. Results: During TRO, the average percent deviation from the targeted flow was lower than 15.9% for all cohorts. Average renal flow rates were significantly different across all cohorts during TRO phase (P < 0.0001; TRO300 = 63.1 ± 1.2; TRO500 = 133.70 ± 1.93; TRO700 = 109.3 ± 2.0), with the TRO700 cohort having less renal flow than TRO500. The TRO500 and TRO700 average renal flow rates inverted during the intensive care unit phase (P < 0.0001; TRO300 = 86.20 ± 0.40; TRO500 = 148.50 ± 1.45; TRO700 = 181.1 ± 0.70). There was higher blood urea nitrogen, creatinine, and potassium in the TRO300 cohort at the end of the experiment, but no difference in lactate or pH between cohorts. Conclusion: This study demonstrated technical feasibility of TRO as a strategy to improve outcomes after prolonged periods of aortic occlusion and resuscitation in the setting of ongoing solid organ hemorrhage. A dose-dependent ischemic end-organ injury occurs beginning with partial aortic occlusion that progresses through the critical care phase, with exaggerated effect on renal function.
Mix and Mesh: An Electronic Database of FPMRS Mesh Products Through 2020
Woodburn, Katherine L. , Fitzgerald, Jocelyn , Cardenas-Trowers, Olivia O, Cardenas-Trowers, Olivia O.

Mayo Clinic

Female Pelvic Medicine & Reconstructive Surgery | March 2, 2022 | Volume: 28 | Issue: 6 | Pages: e154-e156

10.1097/spv.0000000000001158 | PMID 35234182 Get It

Importance A sequelae of the removal of pelvic organ prolapse (POP) transvaginal mesh products from the U.S. market is that current and future women's health providers may be unfamiliar with mesh products historically used to treat pelvic floor disorders. Objectives Our goal was to create an easily accessible resource to address this knowledge gap. Study Design An online database of mesh products used to treat POP and urinary incontinence was created with information, photographs, and videos collated from internet searches; manufacturer materials; and other primary sources. The database was then linked to a free smartphone application. Results This smartphone application includes, to the best of our knowledge, all mesh products used in the United States for the treatment of POP and stress urinary incontinence through December 2020. Included in the application are product descriptions of mesh color, size, design, and attachment points. Photographs and videos, when available, are included. The application is organized by mesh product name, but it is also searchable by other categories, such as manufacturer name and color. To download the application to a smart phone, go to vaginalmeshcatalogue.glideapp.io/ on a web browser or access via the QR code. Once the website is loaded, you can interact with the mesh catalog as a website or save it to the phone's home screen as an application. Conclusions Health care providers of all experience levels can use this free application for educational and clinical purposes to better understand patients' histories, improve preoperative planning, and enhance patient counseling.
A real‐world experience of atrioventricular synchronous pacing with leadless ventricular pacemakers
Kowlgi, Gurukripa N. , Tseng, Andrew S. , Tempel, Nathan D., Henrich, Mark, Venkatachalam, Kalpathi L., Scott, Luis R. , Shen, Win‐Kuang , Deshmukh, Abhishek , Madhavan, Malini , Lee, Hon‐Chi, Asirvatham, Samuel J. , Friedman, Paul A. , Cha, Yong‐Mei , Mulpuru, Siva K. , Henrich, Mark J, Deshmukh, Abhishek J , Tseng, A S , Asirvatham, Samuel J , Kowlgi, Narayan G

Mayo Clinic

Journal of Cardiovascular Electrophysiology | March 2, 2022 | Volume: 33 | Issue: 5 | Pages: 982-993

10.1111/jce.15430 | PMID 35233867 Get It

AbstractAimsThe MicraTM transcatheter pacing system (TPS) (Medtronic) is the only leadless pacemaker that promotes atrioventricular (AV) synchrony via accelerometer‐based atrial sensing. Data regarding the real‐world experience with this novel system are scarce. We sought to characterize patients undergoing MicraTM‐AV implants, describe percentage AV synchrony achieved, and analyze the causes for suboptimal AV synchrony.MethodsIn this retrospective cohort study, electronic medical records from 56 consecutive patients undergoing MicraTM‐AV implants at the Mayo Clinic sites in Minnesota, Florida, and Arizona with a minimum follow‐up of 3 months were reviewed. Demographic data, comorbidities, echocardiographic data, and clinical outcomes were compared among patients with and without atrial synchronous ventricular pacing (AsVP) ≥ 70%.ResultsSixty‐five percent of patients achieved AsVP ≥ 70%. Patients with adequate AsVP had smaller body mass indices, a lower proportion of congestive heart failure, and prior cardiac surgery. Echocardiographic parameters and procedural characteristics were similar across the two groups. Active device troubleshooting was associated with higher AsVP. The likely reasons for low AsVP were small A4‐wave amplitude, high ventricular pacing burden, and inadequate device reprogramming. Importantly, in patients with low AsVP, subjective clinical worsening was not noted during follow‐up.ConclusionWith the increasing popularity of leadless pacemakers, it is paramount for device implanting teams to be familiar with common predictors of AV synchrony and troubleshooting with MicraTM‐AV devices.
We Live in Interesting Times: How Health Services Research and Managerial Epidemiology Helps Point the Way Forward
Garrison, Gregory M.

Mayo Clinic

Health Services Research and Managerial Epidemiology | March 2, 2022 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/23333928221083061 | PMID 35252473 Get It

Correction: Risk factors and long-term course of gastroesophageal reflux disease after peroral endoscopic myotomy: A large-scale multicenter cohort study in Japan
Shiwaku, Hironari , Sato, Hiroki , Shimamura, Yuto , Shiota, Junya , Ominami, Masaki , Sakae, Hiroyuki , Hata, Yoshitaka , Fukuda, Hisashi , Ogawa, Ryo , Tatsuta, Tetsuya , Yokomichi, Hiroshi , Inoue, Haruhiro , Sakae, Hiroyuki , Hata, Yoshitaka , Shimamura, Yuto , Abe, Hirofumi , Sato, Chiaki , Nakamura, Jun , Ikebuchi, Yuichiro , Hasegawa, Suguru

Mayo Clinic

Endoscopy | March 1, 2022 | Volume: 54 | Issue: 09 | Pages: C13-C13

10.1055/a-1778-9730 | PMID 35231941 Get It

Finite Element Modeling of Quantitative Ultrasound Analysis of the Surgical Margin of Breast Tumor
Paul, Koushik , Razmi, Samuel E. , Pockaj, Barbara A. , Ladani, Leila , Stromer, Jeremy, Razmi, Samuel

Mayo Clinic

Tomography | March 1, 2022 | Volume: 8 | Issue: 2 | Pages: 570-584

10.3390/tomography8020047 | PMID 35314624 Get It

Ultrasound is commonly used as an imaging tool in the medical sector. Compared to standard ultrasound imaging, quantitative ultrasound analysis can provide more details about a material microstructure. In this study, quantitative ultrasound analysis was conducted through computational modeling to detect various breast duct pathologies in the surgical margin tissue. Both pulse-echo and pitch-catch methods were evaluated for a high-frequency (22–41 MHz) ultrasound analysis. The computational surgical margin modeling was based on various conditions of breast ducts, such as normal duct, ductal hyperplasia, DCIS, and calcification. In each model, ultrasound pressure magnitude variation in the frequency spectrum was analyzed through peak density and mean-peak-to-valley distance (MPVD) values. Furthermore, the spectral patterns of all the margin models were compared to extract more pathology-based information. For the pitch-catch mode, only peak density provided a trend in relation to different duct pathologies. For the pulse-echo mode, only the MPVD was able to do that. From the spectral comparison, it was found that overall pressure magnitude, spectral variation, peak pressure magnitude, and corresponding frequency level provided helpful information to differentiate various pathologies in the surgical margin.
Let’s Be Honest: These Medical Malpractice Cases Were a Pain in the Back
Ghaith, Summer , Moore, Gregory P. , Lindor, Rachel A. , Hevesi, Sara , Garcia, Samuel Isaias, Ghiath, Summer, Lindor, Rachel A , Garcia, Samuel, Moore, Gregory

Mayo Clinic

Clinical Practice and Cases in Emergency Medicine | March 1, 2022 | Volume: 6 | Issue: 1 | Pages: 8-12

10.5811/cpcem.2022.1.54908 | PMID 35254238 Get It

Introduction: This series reviews three cases of back pain where a highly morbid diagnosis was missed by an emergency physician and subsequently successfully litigated. Case Report: We review the clinical entities of spinal epidural abscess and cauda equina syndrome, challenging diagnoses that can be easily missed and lead to patient harm if not treated promptly. Here we offer suggestions for recognizing these conditions quickly, performing an adequate history and exam, and using documentation to support decision-making. Conclusion: When confronted with an unfortunate medical outcome, maintaining honesty is of paramount importance in medical-legal environments.